Graham Capital Management L.P. Makes New $506,000 Investment in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Graham Capital Management L.P. purchased a new position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 5,490 shares of the medical instruments supplier's stock, valued at approximately $506,000.

A number of other institutional investors also recently bought and sold shares of the stock. New York State Teachers Retirement System lifted its stake in LeMaitre Vascular by 1.2% during the 4th quarter. New York State Teachers Retirement System now owns 8,189 shares of the medical instruments supplier's stock valued at $755,000 after acquiring an additional 100 shares during the period. Flputnam Investment Management Co. increased its stake in shares of LeMaitre Vascular by 3.6% in the fourth quarter. Flputnam Investment Management Co. now owns 2,923 shares of the medical instruments supplier's stock worth $269,000 after purchasing an additional 102 shares in the last quarter. Norden Group LLC raised its holdings in LeMaitre Vascular by 4.5% during the fourth quarter. Norden Group LLC now owns 2,371 shares of the medical instruments supplier's stock valued at $218,000 after acquiring an additional 103 shares during the period. Blue Barn Wealth LLC raised its stake in LeMaitre Vascular by 4.4% during the 4th quarter. Blue Barn Wealth LLC now owns 2,485 shares of the medical instruments supplier's stock valued at $229,000 after purchasing an additional 104 shares during the period. Finally, Shaker Investments LLC OH lifted its holdings in shares of LeMaitre Vascular by 0.8% in the fourth quarter. Shaker Investments LLC OH now owns 13,948 shares of the medical instruments supplier's stock worth $1,285,000 after buying an additional 112 shares in the last quarter. 84.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other LeMaitre Vascular news, insider Trent G. Kamke sold 2,009 shares of the firm's stock in a transaction that occurred on Wednesday, March 12th. The shares were sold at an average price of $82.12, for a total transaction of $164,979.08. Following the completion of the transaction, the insider now directly owns 5,564 shares of the company's stock, valued at approximately $456,915.68. This trade represents a 26.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 10.79% of the stock is currently owned by insiders.

LeMaitre Vascular Stock Up 1.4%

Shares of LeMaitre Vascular stock traded up $1.19 during midday trading on Monday, hitting $85.96. The company had a trading volume of 253,580 shares, compared to its average volume of 164,954. The company has a fifty day simple moving average of $84.19 and a 200 day simple moving average of $92.94. The stock has a market cap of $1.94 billion, a price-to-earnings ratio of 46.97, a PEG ratio of 2.22 and a beta of 0.86. LeMaitre Vascular, Inc. has a 12-month low of $71.42 and a 12-month high of $109.58.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical instruments supplier reported $0.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.50 by ($0.02). The firm had revenue of $59.87 million during the quarter, compared to analysts' expectations of $57.61 million. LeMaitre Vascular had a return on equity of 13.15% and a net margin of 19.40%. The business's revenue was up 12.0% on a year-over-year basis. During the same quarter last year, the business earned $0.44 EPS. As a group, analysts expect that LeMaitre Vascular, Inc. will post 1.94 EPS for the current year.

LeMaitre Vascular Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 0.93%. The ex-dividend date is Thursday, May 15th. LeMaitre Vascular's dividend payout ratio is presently 40.40%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on LMAT shares. Barrington Research lowered shares of LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. Lake Street Capital raised their price target on shares of LeMaitre Vascular from $105.00 to $110.00 and gave the stock a "buy" rating in a research note on Friday, February 28th. Wells Fargo & Company initiated coverage on LeMaitre Vascular in a report on Thursday, February 13th. They issued an "equal weight" rating and a $95.00 price objective for the company. Finally, Oppenheimer cut LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. Five analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, LeMaitre Vascular currently has an average rating of "Moderate Buy" and an average target price of $98.14.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.